Literature DB >> 31454592

Examining the association between bullying victimization and prescription drug misuse among adolescents in the United States.

Philip Baiden1, Savarra K Tadeo2.   

Abstract

BACKGROUND: Although studies have examined the association between bullying victimization and adolescent substance behaviors, there is a dearth of research investigating the association between bullying victimization and prescription drug misuse. The objective of this study was to examine the cross-sectional association between bullying victimization and prescription drug misuse among adolescents.
METHODS: Data for this study came from the 2017 Youth Risk Behavior Survey. A sample of 9974 adolescents aged 14-18 years (50.1% female) were analyzed using binary logistic regression with prescription drug misuse as the outcome variable and bullying victimization as the main explanatory variable.
RESULTS: Of the 9,974 adolescents, 13.1% misused prescription drugs. One in ten adolescents were victims of both school bullying and cyberbullying, 5.1% were victims of only cyberbullying, 9% were victims of only school bullying, and 75.8% experienced neither school bullying nor cyberbullying victimization. In the binary logistic regression model, adolescents who experienced both school bullying and cyberbullying victimization had 1.66 times higher odds of misusing prescription drugs (AOR = 1.66, p < .001, 95% CI = 1.34-2.06) and adolescents who experienced only school bullying victimization had 1.30 times higher odds of misusing prescription drugs (AOR = 1.30, p < .05, 95% CI = 1.02-1.64). Being lesbian, gay, or bisexual; feeling sad or hopeless; cigarette smoking; binge drinking; cannabis use; and illicit drug use were statistically significantly associated with prescription drug misuse.
CONCLUSIONS: Understanding the association between bullying victimization and prescription drug misuse could contribute to early identification of adolescents who may misuse prescription drugs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Keywords:  Cyberbullying victimization; Prescription drug misuse; School bullying victimization; Substance use

Year:  2019        PMID: 31454592     DOI: 10.1016/j.jad.2019.08.063

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Association between aggressive and non-fatal suicidal behaviors among U.S. high school students.

Authors:  Chiung M Chen; Thomas C Harford; Bridget F Grant; S Patricia Chou
Journal:  J Affect Disord       Date:  2020-09-01       Impact factor: 4.839

2.  Factors Affecting Painkillers, Sedatives/Hypnotics, Nicotine, and Unhealthy Alcohol Use Among Gay and Bisexual Men in Taiwan.

Authors:  Dian-Jeng Li; Shiou-Lan Chen; Yu-Ping Chang; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2020-01-29       Impact factor: 3.390

3.  Cyber-Victimization Experience among Higher Education Students: Effects of Social Support, Loneliness, and Self-Efficacy.

Authors:  Tali Heiman; Dorit Olenik-Shemesh
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

4.  Age at first alcohol use and weapon carrying among adolescents: Findings from the 2019 Youth Risk Behavior Survey.

Authors:  Philip Baiden; Nusrat Jahan; Henry K Onyeaka; Shawndaya Thrasher; Savarra Tadeo; Erin Findley
Journal:  SSM Popul Health       Date:  2021-05-15

5.  Racial/Ethnic Bullying Subtypes and Alcohol, Tobacco, and Marijuana Use Among US Adolescents.

Authors:  Jun Sung Hong; Dong Ha Kim; Simon C Hunter; Leah R Cleeland; Carol A Lee; Jane J Lee; Jinwon Kim
Journal:  J Racial Ethn Health Disparities       Date:  2021-06-21

6.  The Impact of Emotional Symptoms and Family Support on the Association Between Homophobic Bullying and Sedative/Hypnotic Use among Gay and Bisexual Men in Taiwan: A Moderated Mediation Model.

Authors:  Dian-Jeng Li; Yu-Ping Chang; Yi-Lung Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2020-05-29       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.